Derma Sciences, Inc. (NASDAQ: DSCI) today announced that the underwriter of its recent public offering has exercised its over-allotment option ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE